Psychedelic-Assisted Psychotherapy: Contrasting Visions

As the field of psychedelic-assisted psychotherapy (PAP) rapidly expands, clinicians need to understand the many contrasting theoretical frameworks and perspectives that are emerging. This conference will empower participants to assess this complex landscape and its divergent visions and provide essential learning to engage with PAP as a cutting-edge therapeutic tool.

With presentations by leading clinicians and researchers plus panel discussions and interaction with attendees, this conference will present current evidence and address critical issues, including: Are psychedelic compounds more effective when they "assist" a particular therapeutic modality? Can clinicians safely and effectively combine psychedelics with their own styles and approaches? Are group or individual therapy models more effective for some populations? Does PAP need to be tailored for clients with traditionally marginalized identities and if so, how?

In order to navigate the rapidly changing PAP landscape and patients' ever-growing interest, clinicians need knowledge and insights to critically understand the field and its clinical implications. Given the multiple stakeholders involved, including pharmaceutical and other for-profit companies, government agencies and academic research institutions and grassroots community organizers, clinicians may struggle with what to believe, who to trust and how to advise their patients. This conference will provide the knowledge and confidence necessary to assess the contrasting — and sometimes competing — visions of PAP from both theoretical and practical perspectives.

Join us in February to explore these contrasting visions. All clinicians who are interested in learning more about the potential of psychedelics in psychotherapy are welcome to attend, with both in-person and online options available. We look forward to an expansive, thought-provoking and enriching conference!

Who Should Attend

• Psychologists
• Specialty Physicians
• Primary Care Physicians
• Nurse Practitioners
• Social Workers
• Counselors

Learning Objectives

Upon completion of this activity, participants will be able to:

• Review the current main themes in PAP research, policy and clinical care.
• Describe several models of psychotherapy that are being used in conjunction with PAP and how they differ.
• Outline the complexity of each care model and identify key components of each.
• Summarize the historical and current disparities in access to and use of psychedelics in LGBTQ+ and populations of color.
• Assess obstacles to PAP among marginalized groups as well as its potential benefits for treating identity-related trauma.
• Compare and contrast different visions that have arisen in the field, such as academic vs. "real-world" settings; for-profit vs non-profit clinical delivery systems; individual vs. group and Western vs. Indigenous therapeutic paradigms.

For a list of session-specific learning objectives, email cme@challiance.org

ABMS/ACGME Competencies

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

• Medical Knowledge
• Interpersonal and Communication Skills
• Professionalism
• Patient Care and Procedural Skills

IOM Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

• Provide Patient-Centered Care
• Employ Evidence-Based Practice

Questions?

Please contact the Continuing Education Programs with any questions by email at ceprograms@hms.harvard.edu or phone at (617) 384-8600.

Alexander Belser, PhD

Licensed Psychologist in Private Practice; Psychedelic Researcher; Founding President, Nautilus Sanctuary; Former Chief Clinical Officer, Cybin Inc.

Seema Desai, MD

Psychiatrist; Study Therapist, Ketamine Assisted Psychotherapy Psychiatric Services, MAPS; Assistant Clinical Professor of Psychiatry, NYU School of Medicine

Neşe Devenot, PhD

Senior Lecturer, Johns Hopkins University; Postdoctoral Associate, Institute for Research in Sensing (IRiS)Postdoctoral Associate, Institute for Research in Sensing (IRiS), University of Cincinnati

Sonya Faber, PhD, MBA

Medical Science Liaison - Neurology, Angelini Pharma; Adjunct Professor, Epidemiology and Public Health, Faculty of Medicine, University of Ottawa

Rheinila Fernandes, MD

Psychiatrist in private practice, Cambridge, MA; Therapist and Sub-Investigator, Multidisciplinary Association for Psychedelic Studies

Genesee Herzberg, PsyD

Psychologist; Founder, Sage Integrative Health and Alchemy Community Therapy Center (formerly Sage Institute), Berkeley, CA; Educator and Consultant, MAPS Public Benefit Corporation

Grant Jones, MA

Student, Clinical Psychology PhD Program, Harvard University; Co-founder, The Black Lotus Collective

Marcela Ot'alora, MA, LPC

Principal Investigator, MDMA-Assisted Therapy Research, MAPS Public Benefit Corporation

Ariel Richer, LMSW, PhD

Assistant Professor, University of Utah College of Social Work; Co-founder/Director, Urban Indigenous Collective

Richard Schwartz, PhD

President, IFS Institute; Teaching Associate, Harvard Medical School

Darron Smith, PhD, PA-C

Associate Professor in the Department of Family Medicine (MEDEX), and Co-Director for the Center for Novel Therapeutics in Addiction Psychiatry, University of Washington; Member of the Board of Directors, American Psychedelic Prescribers Association; Director of Education, Alma Institute.

Joe Tafur, MD

Integrative Family Physician, Curandero, Author and Speaker

Gita Vaid, MD

Board Certified Psychiatrist and Psychoanalyst; Faculty, Institute for Psychoanalytic Education and NYU Department of Psychiatry; Training therapist, Multidisciplinary Association for Psychedelic Studies

Course Directors

Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.

Ronald D. Siegel, PsyD

Faculty, Center for Mindfulness and Compassion, Cambridge Health Alliance
Assistant Professor of Psychology (part-time), Department of Psychiatry, Harvard Medical School
Faculty, Institute for Meditation and Psychotherapy

Laura Warren, MD

Faculty Member, Department of Psychiatry, Cambridge Health Alliance
Faculty and Mentor, CHA Center for Mindfulness and Compassion
Part-time Lecturer in Psychiatry, Harvard Medical School
Board Member, Institute for Meditation and Psychotherapy

James Hopper, PhD

Consultant, Outpatient Addictions Service, Cambridge Health Alliance
Teaching Associate in Psychology, Department of Psychiatry, Harvard Medical School
Therapist and Sub-Investigator, Multidisciplinary Association for Psychedelic Studies

Monnica Williams, PhD

Canada Research Chair for Mental Health Disparities, Director of the Laboratory for Culture and Mental Health Disparities, and Associate Professor, School of Psychology, University of Ottawa, Canada
Clinical Director, Behavioral Wellness Clinic, LLC

Karen Kuc, MPH

Director, Continuing Education in Psychiatry, Cambridge Health Alliance​​​
Associate in Psychiatry, Harvard Medical School

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The Harvard Medical School designates this live activity for a maximum of 13.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychologists

The Cambridge Health Alliance, Psychiatry Continuing Education Division, is approved by the American Psychological Association to sponsor continuing education for psychologists. The Cambridge Health Alliance, Psychiatry Continuing Education Division, maintains responsibility for this program and its content. This course offers 13.00 continuing education credits.

Social Workers

This program has been approved for 13.0 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. NASW-MA Chapter CE Approving Program, Authorization Number D-92191. NY Social Workers: The Division of Continuing Education in Psychiatry at Cambridge Health Alliance is recognized by the New York State Education Department's State Board for Social Work as an Approved Provider #0038 of continuing education for licensed social workers. This course has been approved for 13.0 contact hours.

Counselors

The Cambridge Health Alliance, Psychiatry Continuing Education Division, has been approved by the National Board for Certified Counselors (NBCC) as an approved Continuing Education Provider, ACEP No. 5444. This program meets the requirements for 13.0 continuing education hours. CHA is solely responsible for all aspects of the program. This offering is also applicable for Commonwealth of Massachusetts Counseling/Allied Mental Health accreditation for 13.00 credits.

Physician Assistants, Nurse Practitioners and Registered Nurses

For the purpose of recertification, the National Commission on Certification of Physician Assistants, the American Academy of Nurse Practitioners Certification Board and the American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

Canadian Accreditation

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

European Accreditation

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found here.

Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclaimer

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Hotel Reservations

All sessions will be held at:

Fairmont Copley Plaza Boston
138 Saint James Avenue
Boston MA 02116

A block of rooms for the nights of February 8th, 9th, and 10th 2024 has been reserved at the hotel for this event, under the group name Cambridge Health Alliance. All reservations must be made, modified or canceled individually through the hotel's Reservation Department via this direct link https://book.passkey.com/go/CHAPsychedelic2024 or by calling 1-800-441-1414 and referring to Group Name.

Reservations for rooms accessible to guests with disabilities may be made in the same manner.

Reservations must be made on or before Jan 15, 2024 to guarantee the CHA group rate.

Hotel confirms the following guest room rates per night:

• Single occupancy: $199
• Double occupancy: $209 (single or double bedded)
• Deluxe room: $249

Guest room rates are exclusive of applicable taxes and service fees.